Pharvaris Netherlands B.v.

This study tests a once-daily pill called deucrictibant to prevent sudden swelling attacks in people aged 12 and older with hereditary angioedema (HAE). The goal is to see if the drug is safe and effective over the long term. About 170 participants will take the pill and be monit…

This study tests an oral medication called deucrictibant for adults with acquired angioedema, a rare condition causing sudden, painful swelling. The drug comes in two forms: a long-acting tablet to prevent attacks and a fast-acting capsule to stop attacks once they start. About 3…